S. Jarosz et al. / Tetrahedron: Asymmetry 13 (2002) 2223–2228
2227
4.2.2.
4-(3%-O-Benzyl-1%,2%-O-isopropylidene-a-
D
-xylo-
3.27 (m, H-3a and H-7a), 2.82 (m, H-4), 2.77 and 2.23
(2m, both H-7); 13C NMR l: 178.9 and 177.5 (2×CꢀO),
131.7 (C-5), 127.3 (C-6), 78.4 (C-2%), 73.4 and 72.0
(2×CH2Ph), 68.1 (C-1%), 41.3 (C-3a), 40.8 (C-7a), 37.8
(C-4,), 24.6 (C-7); HRMS (LSIMS) m/z: 490.1982
[C30H29O4NNa (M+Na+) requires 490.1994]. NOE:
H4ꢁH3a, H4ꢁH7a.
tetros - 4 - yl) - 2 - phenyl - (3aR,4S,7aR) - tetrahydro - iso-
indole-1,3-dione, 11. [h]D −40.3 (c 1.3); mp=189–190°C;
1H NMR l: 6.13 (dt, J4,5=J5,7 3.4, J5,6 9.3, H-5), 5.99
(m, H-6), 5.97 (d, J1%,2% 4.0, H-1%), 4.79 (dd, J3%,4% 3.1, J4%,4
10.5, H-4%), 4.70 (d, J2%,3% 0, H-2%), 4.37 (d, H-3%), 3.12
(ddd, J7,7a 1.4, and 7.7, J3a,7a 9.1, H-7a), 2.96 (dd, J3a,4
5.7, H-3a), 2.78 (ddd, J6,7 7.0, J7,7 15.4, H-7), 2.76 (m,
H-4), 2.21 (m, H-7), 1.50 and 1.33 [C(CH3)2]; 13C NMR
l: 178.7 and 176.9 (2×CꢀO), 131.7 and 129.3–126.5
(Carom, C-5,6), 111.6 [C(CH3)2], 104.8 (C-1%), 82.4, 81.5
and 80.0 (C-2%,3%,4%), 71.4 (CH2Ph), 40.7 and 40.2 (C-
3a,7a), 35.0 (C-4), 26.8 and 26.3 [C(CH3)2], 24.5 (C-7);
HRMS (LSIMS) m/z: 476.2069 [C28H29NO6 (M+H+)
requires 476.2073]. Anal. calcd for C28H30NO6 (475.54):
C, 70.72; H, 6.15; N, 2.94. Found: C, 70.59; H, 6.18; N,
2.99. NOE: H4ꢁH3a, H3aꢁH-7a.
4.3. Degradation of compound 10, the major isomer
from reaction of 5 with 9
Major stereoisomer 10 (100 mg) was dissolved in ethyl
acetate (10 mL) and hydrogenated under standard con-
ditions (H2/Pd, overnight). The catalyst was filtered off
through Celite and the solvent was evaporated to dry-
ness. The 13C NMR spectrum of the pure intermediate
thus obtained indicated the saturation of the C5ꢁC6
double bond and removal of the benzyl protecting
group from the C-3% position of the sugar moiety. 13C
NMR l: 179.1 and 176.9 (2×CꢀO), 112.3 (CMe2), 104.1
(C-1%), 85.3, 80.0 and 74.1 (C-2%,3%,4%) 41.1, 40.5 and
33.1 (C-4,3a,7a), 27.5 and 27.3 (CMe2), 25.6, 22.6, 20.5
(C-5,6,7).
4.2.3. 4-(Methyl 2%,3%-di-O-benzyl-b-L-arabino-tetrosid-4-
yl)-2-phenyl-3aS,4R,7aS)-tetrahydro-iso-indole-1,3-
dione, 13. [h]D −106.0 (c 1); 1H NMR l: 5.97 (m, H-5,6),
4.98 (s H-1%), 4.72 (dd, J3%,4% 6.1, J4%,4 11.1 H-4%), 4.03 (d,
J2%,3% 1.8, H-2%), 3.73 (dd, H-3%), 3.63 (dd, J4,3a 5.8, J7a,3a
11.1, H-3a), 3.43 (OCH3), 3.26 (m, H-7a), 2.81 and 2.18
(2×m, both H-7), 2.52 (m, H-4); 13C NMR l: 178.9 and
176.2 (2×CꢀO), 129.0–126.5 (C-5,6 and Ph), 106.0 (C-
1%), 88.8, 87.7 and 79.1 (C-2%,3%,4%), 72.1 and 72.0 (2×
CH2Ph), 54.2 (OCH3), 41.4, 41.1 and 39.9 (C-4,3a,7a),
24.9 (C-7); HRMS (LSIMS) m/z: 562.2191
[C33H33NNaO6 (M+Na+) requires 562.2206]. NOE:
H4ꢁH3a, H3aꢁH-7a.
This crude product was dissolved in THF (10 mL),
sulfuric acid (10% solution in water, 2 mL) was added
and the mixture was heated under reflux for 24 h. After
cooling to rt, the acid was carefully neutralized with
triethylamine and mixture was poured into ether (10
mL) and water (10 mL). Sodium periodate (300 mg)
was added, the mixture was vigorously stirred for 1 h
and partition between ether (20 mL) and water (10
mL). The organic lawyer was separated washed with
water, dried and concentrated. The crude product was
dissolved in THF/MeOH (5 mL, 3:1 v/v) and reduced
with sodium borohydride (50 mg) under standard con-
ditions. Acetylation of the crude material with Ac2O/
py, followed by chromatographic purification
(hexane–ethyl acetate, 5:13:1) afforded 14 (30 mg).
4.2.4. 4-(Methyl 2%,3%-di-O-benzyl-b-L-arabino-tetrosid-4-
yl)-2-phenyl-(3aR,4S,7aR)-tetrahydro-iso-indole-1,3-
1
dione, 12. [h]D 82.2 (c 1.4); H NMR l: 6.02 (m, H-6),
5.88 (m, H-5), 4.81 (d, J1%,2% 1.8, H-1%), 4.63 (dd, J3%,4% 7.1,
J4%,4 4.9, H-4%), 4.01 (dd, J2%,3% 3.9, H-2%), 3.85 (dd, H-3%),
3.21 (m, H-7a), 3.20 (OCH3), 3.15 (dd, J4,3a 6.8, J3a,7a
9.4, H-3a), 2.77–2.67 (m, H-4,7), 2.29 (m, second H-7);
13C NMR l: 129.4–126.5 (C-5,6 and Ph), 107.3 (C-1%),
88.2, 84.3 and 80.1 (C-2%,3%,4%), 72.2 and 71.9 (2×
CH2Ph), 55.5 (OCH3), 42.1, 39.7 and 37.4 (C-4,3a,7a),
23.3 (C-7); HRMS (LSIMS) m/z: 562.2191
[C33H33NNaO6 (M+Na+) requires 562.2206]. NOE:
H4ꢁH3a, H3aꢁH-7a.
4.3.1. 4-(Acetoxymethyl)-2-phenyl-(3aS,4R),7aS)tetra-
hydro-iso-indole-1,3-dione, 14. [h]D −12.1 (c 3.6), 13C
NMR l: 170.8 (×2) and 170.1 (3×CꢀO), 67.1
(CH2OAc), 44.6 and (2×) 39.8 (C-3a,4,7a), 24.9 and
(2×) 23.9 (C-5,6,7), 21.0 (COCH3); HRMS m/z:
370.1299 [C18H21NO6 [M+HCOOH+Na+) requires
370.1267].
4.2.5. 4-[1%,2%(S)-Di-O-benzyloxyethane-2%-yl)-2-phenyl-
(3aS,4R,7aS)-tetrahydro-iso-indole-1,3-dione, 16. [h]D
−87.3 (c 2.1); H NMR l: 6.00 (m, H-6), 5.88 (m, H-5),
1
4.41 (ddd, J 11.2, 3.1, and 4.0, H-2%), 3.78 (m, H-3a and
H-1%), 3.64 (dd, J1%,1% 10.8, second H-1%), 3.27 (m, H-7a),
2.80 (ddd, J7,7a 1.2 and 7.4 J7,7 15.2, H-7), 2.68 (m, H-4),
2.22 (m, second H-7); 13C NMR l: 179.1 and 177.6
(2×CꢀO), 130.2(C-5), 127.5 (C-6), 77.5 (C-2%), 73.3 and
72.5 (2×CH2Ph), 70.5 (C-1%), 40.5 (C-3a), 40.1 (C-7a),
38.9 (C-4), 25.4 (C-7); HRMS (LSIMS) m/z: 490.1966
[C30H29O4NNa (M+Na+) requires 490.1994]. NOE:
H4ꢁH3a, H4ꢁH7a (weak), H3aꢁH-7a.
4.4. Degradation of compound 13, the major isomer from
reaction of 6 with 9
This reaction was performed as detailed above for
compound 10. The product had identical spectral data
as 14 (13C NMR and MS); [h]D −10.4 (c 1, CHCl3).
4.2.6. 4-[1%,2%(S)-Di-O-benzyloxyethane-2%-yl)-2-phenyl-
(3aR,4S,7aR)-tetrahydro-iso-indole-1,3-dione 17. [h]D
+11.5 (c 2.1); 1H NMR l: 6.04 (dt, J5,6 9.3, J4,5=J5,7 3.2,
H-5), 5.98 (m, H-6), 4.20 (m, H-2%), 3.94 (m, both H-1%),
4.5. Crystal structure data for compound 10
For crystal structure data for compound 10, see Table
1.